Gestational diabetes & diabetes in pregnancy

Sensor‐derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart—A secondary analysis of the CopenFast trial

Diabet MedPublished Secondary analysis of the CopenFast randomised trial

Primary result · TIRp (3.5-7.8 mmol/L)Result — go to the resultEstimated treatment difference 5.1 % 95% CI 0.3–9.7

Authors' conclusion

Women using faster aspart achieved more TIRp and experienced less severe hypoglycaemia compared to women using IAsp. Infant birthweight was lower and thereby more appropriate in the faster aspart group; however, this attenuated when adjusting for parity.

Study context

Population
Pregnant women with T1D using intermittently scanned continuous glucose monitoring (isCGM) during pregnancy91% of 124 isCGM users
Participants
113 women
Comparison
Faster aspart vs insulin aspart (IAsp)
Methodological detailspre-planned secondary analysis
  • Pre-planned secondary analysis

Primary result

TIRp (3.5-7.8 mmol/L) · 22 to 33 weeks

Estimated treatment difference

5.1 %

95% CI 0.3–9.7

P = 0.04

Faster aspartvs IAsp
estimated treatment difference 5.1 % (95% CI 0.3–9.7); P = 0.04

As reported in the abstract

Further findings

OutcomeEstimated treatment difference (CI)P value
Infant birthweight SD score−0.5 (−0.9 to −0.03)P = 0.04
Infant birthweight SD score — Attenuated when adjusting for parity
p = 0.10

Time below range in pregnancy (TBRp) (<3.5 mmol/L) · throughout pregnancy

TBRp remained stable around 4% in both groups

Safety

≥1 severe hypoglycaemic event

OR (abstract does not state which group each count belongs to; OR lies outside its printed interval)
0.93 [−0.2; −0.01]
P
P = 0.04

Original publication

Sensor‐derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart—A secondary analysis of the CopenFast trial. Diabet Med. Published 4 November 2024. doi:10.1111/dme.15467

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.